Tenax Therapeutics Faces Securities Class Action Lawsuit
Investors who purchased Tenax Therapeutics stock between November 2023 and August 2026 are invited to join a class action lawsuit.
Rosen Law Firm has initiated a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) following allegations of potential securities fraud. The legal action pertains to investors who acquired company shares between November 13, 2023, and August 7, 2026.
The lawsuit asserts that Tenax Therapeutics provided misleading information to the market regarding its business operations and clinical development status during the specified period. The filing seeks to recover damages for shareholders who claim their investment value was negatively impacted by these disclosures.
Investors currently have until a designated deadline to apply to the court to serve as lead plaintiff. The outcome of this litigation will depend on evidence presented regarding the firm's regulatory and financial communications.